<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08594161371984</udiDi>
    <basicUdiDi>B-08594161371984</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:45.614Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371977</udiDi>
    <basicUdiDi>B-08594161371977</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:44.810Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371960</udiDi>
    <basicUdiDi>B-08594161371960</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:44.004Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371946</udiDi>
    <basicUdiDi>B-08594161371946</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:43.206Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371939</udiDi>
    <basicUdiDi>B-08594161371939</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:39.197Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371922</udiDi>
    <basicUdiDi>B-08594161371922</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:38.397Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371878</udiDi>
    <basicUdiDi>B-08594161371878</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:37.605Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371861</udiDi>
    <basicUdiDi>B-08594161371861</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:36.792Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371854</udiDi>
    <basicUdiDi>B-08594161371854</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:32.791Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371847</udiDi>
    <basicUdiDi>B-08594161371847</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:31.995Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371717</udiDi>
    <basicUdiDi>B-08594161371717</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:31.196Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371700</udiDi>
    <basicUdiDi>B-08594161371700</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:30.394Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371694</udiDi>
    <basicUdiDi>B-08594161371694</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:27.849Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371687</udiDi>
    <basicUdiDi>B-08594161371687</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Estonia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:25.697Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371632</udiDi>
    <basicUdiDi>B-08594161371632</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:24.013Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371533</udiDi>
    <basicUdiDi>B-08594161371533</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:23.205Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371472</udiDi>
    <basicUdiDi>B-08594161371472</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:19.205Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371311</udiDi>
    <basicUdiDi>B-08594161371311</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:18.424Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371304</udiDi>
    <basicUdiDi>B-08594161371304</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:18.105Z</lastUpdated>
  </row>
  <row>
    <udiDi>08594161371298</udiDi>
    <basicUdiDi>B-08594161371298</basicUdiDi>
    <tradeName>ENTEROSGEL®</tradeName>
    <deviceName>ENTEROSGEL</deviceName>
    <manufacturerName>Bioline Products s.r.o.</manufacturerName>
    <manufacturerSrn>CZ-MF-000034917</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-07-07T22:47:17.285Z</lastUpdated>
  </row>
</eudamedExport>